Pelamed Pharmaceuticals had EBIT of $276.58 million in 2018. In addition, Pelamed had interest expenses of $86.07 million and a corporate tax rate of 25%. a. What was Pelamed's 2018 net income? b. What was the total of Pelamed's 2018 net income plus interest payments? c. If Pelamed had no interest expenses, what would have been its 2018 net income? How does it compare to your answer in part (a)? d. What was the amount of Pelamed's interest tax shield in 2018